Discover how the innovative pharmaceutical industry works with partners to advance the SDGs
Read moreOn 6 February 2023, IFPMA delivered a statement for the WHO EB152 agenda item related to the Pandemic Influenza Preparedness Framework.
Read moreIFPMA statement on behalf of the pharmaceutical industry at the Convention on Biological Diversity (CBD) COP 15 meeting regarding Digital Sequence Information.
Read more